NCT01091532
- Conditions
- Multiple Dose, Pharmacokinetic, Phase 1, +2 more
- Locations
-
- Pfizer Investigational Site Brussels, Belgium
Clinical trial condition
Explore clinical trials studying Toleration. Study availability and eligibility vary by location and protocol.
NCT01091532
NCT01415102